Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound Guided TPVB for Pain Control in Liver RFA
NCT02271646Completed
- Sponsor
- Mahidol University
- Start
- Aug 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bupivacaine in liver cancer, sponsored by Mahidol University. Primary endpoint: Pain score at recovery room both at rest and movement (cough) up to 24 hours. Started Aug 2014; status: completed.
02
Drugs
bupivacaine
03
Conditions
liver cancer
Beyond the preview
Go deeper on NCT02271646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02271646.